Cargando…

Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK

OBJECTIVES: To develop a computer-based decision support tool (DST) for key decision makers to safely explore the impact on chronic obstructive pulmonary disease (COPD) care of service changes driven by restrictions to prevent the spread of COVID-19. DESIGN: The DST is powered by discrete event simu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakutcan, Usame, Hurst, John R, Lebcir, Reda, Demir, Eren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556746/
https://www.ncbi.nlm.nih.gov/pubmed/36207043
http://dx.doi.org/10.1136/bmjopen-2022-062305
_version_ 1784807140345511936
author Yakutcan, Usame
Hurst, John R
Lebcir, Reda
Demir, Eren
author_facet Yakutcan, Usame
Hurst, John R
Lebcir, Reda
Demir, Eren
author_sort Yakutcan, Usame
collection PubMed
description OBJECTIVES: To develop a computer-based decision support tool (DST) for key decision makers to safely explore the impact on chronic obstructive pulmonary disease (COPD) care of service changes driven by restrictions to prevent the spread of COVID-19. DESIGN: The DST is powered by discrete event simulation which captures the entire patient pathway. To estimate the number of COPD admissions under different scenario settings, a regression model was developed and embedded into the tool. The tool can generate a wide range of patient-related and service-related outputs. Thus, the likely impact of possible changes (eg, COVID-19 restrictions and pandemic scenarios) on patients with COPD and care can be estimated. SETTING: COPD services (including outpatient and inpatient departments) at a major provider in central London. RESULTS: Four different scenarios (reflecting the UK government’s Plan A, Plan B and Plan C in addition to a benchmark scenario) were run for 1 year. 856, 616 and 484 face-to-face appointments (among 1226 clinic visits) are expected in Plans A, B and C, respectively. Clinic visit quality in Plan A is found to be marginally better than in Plans B and C. Under coronavirus restrictions, lung function tests decreased more than 80% in Plan C as compared with Plan A. Fewer COPD exacerbation-related admissions were seen (284.1 Plan C vs 395.1 in the benchmark) associated with stricter restrictions. Although the results indicate that fewer quality-adjusted life years (in terms of COPD management) would be lost during more severe restrictions, the wider impact on physical and mental health must also be established. CONCLUSIONS: This DST will enable COPD services to examine how the latest developments in care delivery and management might impact their service during and beyond the COVID-19 pandemic, and in the event of future pandemics.
format Online
Article
Text
id pubmed-9556746
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-95567462022-10-14 Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK Yakutcan, Usame Hurst, John R Lebcir, Reda Demir, Eren BMJ Open Respiratory Medicine OBJECTIVES: To develop a computer-based decision support tool (DST) for key decision makers to safely explore the impact on chronic obstructive pulmonary disease (COPD) care of service changes driven by restrictions to prevent the spread of COVID-19. DESIGN: The DST is powered by discrete event simulation which captures the entire patient pathway. To estimate the number of COPD admissions under different scenario settings, a regression model was developed and embedded into the tool. The tool can generate a wide range of patient-related and service-related outputs. Thus, the likely impact of possible changes (eg, COVID-19 restrictions and pandemic scenarios) on patients with COPD and care can be estimated. SETTING: COPD services (including outpatient and inpatient departments) at a major provider in central London. RESULTS: Four different scenarios (reflecting the UK government’s Plan A, Plan B and Plan C in addition to a benchmark scenario) were run for 1 year. 856, 616 and 484 face-to-face appointments (among 1226 clinic visits) are expected in Plans A, B and C, respectively. Clinic visit quality in Plan A is found to be marginally better than in Plans B and C. Under coronavirus restrictions, lung function tests decreased more than 80% in Plan C as compared with Plan A. Fewer COPD exacerbation-related admissions were seen (284.1 Plan C vs 395.1 in the benchmark) associated with stricter restrictions. Although the results indicate that fewer quality-adjusted life years (in terms of COPD management) would be lost during more severe restrictions, the wider impact on physical and mental health must also be established. CONCLUSIONS: This DST will enable COPD services to examine how the latest developments in care delivery and management might impact their service during and beyond the COVID-19 pandemic, and in the event of future pandemics. BMJ Publishing Group 2022-10-07 /pmc/articles/PMC9556746/ /pubmed/36207043 http://dx.doi.org/10.1136/bmjopen-2022-062305 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Respiratory Medicine
Yakutcan, Usame
Hurst, John R
Lebcir, Reda
Demir, Eren
Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
title Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
title_full Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
title_fullStr Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
title_full_unstemmed Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
title_short Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
title_sort assessing the impact of covid-19 measures on copd management and patients: a simulation-based decision support tool for copd services in the uk
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556746/
https://www.ncbi.nlm.nih.gov/pubmed/36207043
http://dx.doi.org/10.1136/bmjopen-2022-062305
work_keys_str_mv AT yakutcanusame assessingtheimpactofcovid19measuresoncopdmanagementandpatientsasimulationbaseddecisionsupporttoolforcopdservicesintheuk
AT hurstjohnr assessingtheimpactofcovid19measuresoncopdmanagementandpatientsasimulationbaseddecisionsupporttoolforcopdservicesintheuk
AT lebcirreda assessingtheimpactofcovid19measuresoncopdmanagementandpatientsasimulationbaseddecisionsupporttoolforcopdservicesintheuk
AT demireren assessingtheimpactofcovid19measuresoncopdmanagementandpatientsasimulationbaseddecisionsupporttoolforcopdservicesintheuk